Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least squares (OLS)...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Using Best-Worst Scaling to explore the perceived addictiveness of foods by processing level: a cross-sectional study among higher education students in Belgium.

Archives of public health = Archives belges de sante publique·2026
Same author

Proposed Conceptual and Experience-Based Framework for Reaching an Optimal Vaccine Launch Strategy.

Vaccines·2026
Same author

Vaccine Development, Its Implementation and Price Setting: A Historical Perspective with Proposed Ways to Move Forward.

Journal of market access & health policy·2025
Same author

Authors reply: "An economic model for different anticoagulation strategies in continuous renal replacement therapy".

Journal of critical care·2025
Same author

Uptake of Intermittent Preventive Treatment and Its Associated Factors Among Pregnant Women in Cameroon: A Cross-Sectional Study.

Cureus·2025
Same author

The Health Impact of Using Anti-PD-1 Agents to Treat Early-Stage Cancer in Belgium.

Oncology and therapy·2025

Related Experiment Video

Updated: May 25, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Population- versus cohort-based modelling approaches.

Olivier Ethgen1, Baudouin Standaert

  • 1Department of Public Health Sciences, University of Lige, Lige, Belgium. o.ethgen@ulg.ac.be

Pharmacoeconomics
|January 31, 2012
PubMed
Summary

Healthcare decision models require careful consideration of target population characteristics. Understanding both cohort-based and population-based approaches is crucial for accurate modeling and informed decision-making.

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Related Experiment Videos

Last Updated: May 25, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Area of Science:

  • Health economics
  • Mathematical modeling
  • Decision analysis

Background:

  • Healthcare decision-making relies on models, but a "one-size-fits-all" approach is inadequate.
  • Target populations are heterogeneous and evolve, necessitating accurate representation in models.
  • Current healthcare decision models predominantly use a cohort-based approach, often without explicit justification.

Purpose of the Study:

  • To challenge the default use of cohort-based models in healthcare decision-making.
  • To emphasize the critical importance of target population characteristics in model selection.
  • To advocate for a more informed choice between cohort-based and population-based modeling approaches.

Main Methods:

  • Review and comparison of cohort-based and population-based modeling strategies.
  • Analysis of how target population heterogeneity and dynamics impact model outcomes.
  • Discussion of the implications for healthcare decision-making.

Main Results:

  • No single model type is universally adequate; model choice depends on specific decision problems.
  • Cohort-based models often assume homogeneous populations, potentially oversimplifying reality.
  • Population-based models aim to capture demographic, epidemiological, and clinical characteristics of prevalent populations.

Conclusions:

  • Modellers must prioritize understanding target population characteristics before selecting a modeling approach.
  • Choosing between cohort-based and population-based models should be a deliberate, evidence-based decision.
  • Informed decision-makers require understanding the impact of different modeling approaches on results.